American Society of Hematology, Blood Advances, 22(3), p. 3626-3634, 2019
DOI: 10.1182/bloodadvances.2019000934
Full text: Download
Key Points The machine learning algorithms produced clinically reasonable and robust risk stratification scores for aGVHD. Predicting scores for aGVHD also demonstrated the link between risk of development of aGVHD and overall survival after HSCT.